by La Jolla Institute for Immunology Anti-PD-1 cancer immunotherapies boost the body’s cancer-fighting T cells, but in many patients, suppressive Tfr cells bring that progress to a grinding halt. Credit: La Jolla Institute for Immunology New research led by scientists at La Jolla Institute for Immunology (LJI) and the University of Liverpool may explain why many cancer patients...
by European Society of Cardiology Credit: Unsplash/CC0 Public Domain Nearly one in four patients with heart failure is depressed or anxious, according to a study published during this week’s Heart Failure Awareness Days. Patients with heart failure were 20% more likely to develop these mental health issues during the five years after diagnosis compared to those...
Professor Naoto Hirano of the Temerty Faculty of Medicine and collaborators have developed a new technology that rigorously and robustly identifies the immune cells that are capable of recognizing and eliminating cancer cells. The findings, published in Nature Biotechnology, pave the way for novel immunotherapies to help more patients, regardless of their genetic ancestry, live longer and healthier lives....
by Johannes Angerer, Medical University of Vienna Credit: Pixabay/CC0 Public Domain In a study recently published in the leading journal Blood, Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and...
EUROPEAN SOCIETY OF CARDIOLOGY Sophia Antipolis, 07 October 2019: Patients with cancer should receive a tailored exercise prescription to protect their heart, reports a paper published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).1 ‘Cancer patients are often less active than adults without cancer,’ said author Dr Flavio D’Ascenzi, University of Siena, Italy. ‘However, exercise is essential for patients diagnosed with cancer who are under...
by Queen Mary, University of London A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients. If successful, this non-invasive urine test would be the first in the world to help clinicians detect the highly lethal cancer at an early stage—enabling...
The drug, known as bermekimab, has been hailed as ‘radical’ by experts It blocks a molecule which causes inflammation and pain, its developer says Patients with lung, pancreatic and ovarian cancer will be among the first to try it By VANESSA CHALMERS HEALTH REPORTER FOR MAILONLINE Cancer patients in the UK will test a drug that has been designed to reduce...
By Ted Ranosa Tech Times A new study suggests that physicians are less likely to schedule cancer screenings for patients during the latter part of the day. Researchers at the University of Pennsylvania sought to understand how the time of day can influence doctors’ behavior when providing cancer screenings. They examined medical data collected from 33 primary care practices in Pennsylvania and New Jersey between 2014 and 2016. This included eligible screenings for nearly...
Experts say development of new vaccines might help prevent shingles in cancer patients. The study, of about 240,000 cancer patients in Australia from 2006 to 2015, found that any type of cancer was associated with a 40 percent increased risk of developing shingles, compared with not having cancer. (HealthDay)—Newly diagnosed cancer patients may be at increased risk for the painful skin condition shingles, a new study finds. Patients with a blood-related cancer had the greatest shingles risk—more than three times...
The Next-Generation Copy Number Alteration (NG-CNA) assay can analyze small amounts of material to estimate metastatic risk, reports The Journal of Molecular Diagnostics ELSEVIER Philadelphia, December 12, 2018 – For men newly diagnosed with prostate cancer or patients previously treated, the risk of metastasis is a crucial determinant of whether to choose conservative management or...
